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Abstract
Age-related macular degeneration (ARMD) is the leading cause of blindness 
affecting adults. The disease alters the macula, center of the retina, responsible 
for the keenest vision. Although ARMD is part of the aging process, the exact 
pathophysiology is still unknown. The evidence suggests that oxidative stress, 
lipofuscin accumulation, drusen accumulation, chronic inflammation, choroidal 
neovascularization, and mutations of the complement contribute to the develop-
ment of ARMD. Early recognition and prompt treatment halt the progression of the 
disease. The advanced technology in imaging modalities provides comprehensive 
and complete management at the earliest stage of ARMD.
Keywords: macular degeneration, age-related macular degeneration, imaging, 
fundus photography, fundus autofluorescence, fundus fluorescence angiography, 
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1. Introduction
Macular degeneration or age-related macular degeneration (ARMD) is the 
leading cause of blindness affecting elder individuals. In 2004, it was estimated 
that 1.75 million people over 40 years old in the USA develop ARMD, and the 
number is expected to increase twice the number in the next decades [1]. The 
prevalence of ARMD varies among ethnicity group. A study by Wong et al. 
gathered the pooled prevalence (age ranges from 45 to 85 years) was 8.69%, with 
the highest prevalence found in European decent 11.9% and the lowest among 
Asian decent 6.81% [2]. The progression of the disease is worsening with age, a 
systematic review of European studies found increasing trend of early ARMD 
prevalence from 3.5% in age group 55–59 years to 17.6% in age group >85 years old 
and from 0.1% in those aged 55–59 years to 9.8% in those aged >85 years old for 
late ARMD [3]. Thus, aging is the pivotal factors behind ARMD development and 
progression.
Age at diagnosis of ARMD is the key element to halt ARMD progression 
[4]. Advancement in technology of imaging modalities provides a comprehen-
sive and complete examination of the ocular condition at the earliest stage of 
ARMD. Imaging modalities include fundus photography, fundus fluorescence angi-
ography, indocyanine green angiography (ICGA), fundus autofluorescence, optical 
coherence tomography (OCT), and optical coherence tomography angiography 
(OCTA) [4–7]. This chapter will further discuss the superiority of each modality.
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2. An overview of age-related macular degeneration
Age-related macular degeneration is commonly classified based on its character-
istics into dry (nonexudative) ARMD and wet (exudative) ARMD [5, 7]. Meanwhile, 
according the natural course of the disease, it categorizes into early, intermediate, 
and advanced ARMD [6, 7]. Dry ARMD represents approximately 90% of diagnosed 
ARMD cases [5, 7]. This type is distinguished by the present drusen accumulation, the 
absence of choroid neovascularization, and retinal pigment epithelium (RPE) atrophy 
[8]. The hallmark of wet ARMD is the development of choroidal neovascularization, 
and this fragile new blood vessel tends to leak forming exudates [9]. It counts for 10% of 
ARMD cases and has been linked with rapid deterioration toward blindness [7].
Beyond aging process, smoking and ethnicity are the only consistent risk factors 
related with ARMD documented in studies. A cohort study of 65 years old or older 
patients found smoking doubles the risk of having ARMD in 5 years compared 
to nonsmokers [10]. The exact underlying pathophysiology of ARMD is still 
unknown. Several theories are hypothesized to be the fundamental factors behind 
ARMD. These include lipofuscin accumulation, drusen accumulation, chronic 
inflammation, oxidative stress, reduction of antioxidant, mutation of complements, 
and choroidal neovascularization [10, 11]. The new blood vessels are fragile and 
generate complications to the surrounding structure causing hemorrhages, exudate, 
RPE and/or retinal detachment, and scar, hence the progression into the end-stage 
ARMD, which is exudative ARMD [5, 6, 9, 12].
The identification of ARMD in patients is a crucial aspect in delivering early 
treatment. Elder patients especially those aged above 40 years are more susceptible to 
develop ARMD. According to the American Academy of Ophthalmology, it is sug-
gested that individuals aged 40 years and above should be screened for the possible 
ARMD. Binocular slit-lamp examination with three mirror lens or condensing lens 
is also needed to disclose drusen, profound signs of CNV such as macular edema, 
subretinal fluid, hemorrhages, acclivity of retinal pigment epithelium, and RPE 
atrophy [6]. High-risk individuals are suggested to regularly conduct further compre-
hensive eye examinations. A comprehensive eye examination includes noninvasive 
and invasive imaging to detect any subtle changes in the retina structures [6].
3. Multimodal imaging in age-related macular degeneration
Imaging not only holds an important diagnostic tool in ARMD but also 
provides better understanding of ARMD pathophysiology, determines treat-
ment options, and evaluates the treatment responds and disease progression 
[7, 13]. Imaging aids clinicians to visualize abnormalities exhibited by ARMD 
such as lipofuscin, RPE atrophy, drusen deposits, choroidal neovascularization, 
and subretinal fluid [7, 14, 15]. The characteristics found during the imaging 
determine the treatment options and prognosis of the patient. The various 
modalities are color fundus photography, fundus fluorescence angiography 
(FFA), indocyanine green angiography (ICGA), fundus autofluorescence 
(FAF), optical coherence tomography (OCT), and OCTA [13]. Despite the vari-
ous imaging technologies, fluorescein angiography remains as a gold standard 
for diagnosis of the wet ARMD.
3.1 The role of fundus photography in age-related macular degeneration
Fundus photography (FP) is one of the simplest imaging modalities that can 
be utilized in detecting ARMD. Fundus photography was found at the end of the 
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nineteenth century. In the 1950s, electronic flash and 35 mm cameras were adapted; 
thus modern ophthalmic camera was born. This examination uses fundus camera, 
which projects light into the dilated pupil to illuminate fundus. Fundus camera 
usually possesses 30—35° optical angle of view conceiving a 2.5 times life size 2D 
image [13, 15].
This modality is useful to detect both dry and wet ARMD. It can display 
various ARMD abnormalities consisting lipofuscin, drusen as a yellow deposit, 
reticular pseudodrusen, well-defined area of RPE atrophy, and choroid neovas-
cularization [14, 15]. In nonexudative ARMD, FP allows visualization of drusen 
that appears as yellowish round lesion, pigmentary deposit around macula, 
while atrophic RPE shows a hypopigmentation around the macula. This imaging 
also enables measurement of drusen characteristics and size. The hard drusen 
appears as well-defined border yellow deposit, while soft drusen exhibits an 
ill-defined border yellow deposit [16]. The size of drusen is categorized into small 
(<63 μm), intermediate (63–124 μm), and large (≥125 μm). Figure 1A shows 
the characteristics of soft and hard drusen. This also contributes to staging of 
ARMD. Meanwhile, the utilization of color fundus photography in wet ARMD is 
beneficial in the detection of any exudative complications such as macular edema 
and macular detachment [7].
Regardless of its convenience, color fundus photography has several disadvan-
tages. First, the image created is in 2D and thus lacks depth and generates problem 
in visualizing small details. Any abnormalities in the refractive media such as 
cataract result in lower image clarity [15]. When used as single imaging procedure, 
fundus photography has lower sensitivity to detect choroidal neovascularization 
78% compared to OCT 94% [17]. Fundus photography has better accuracy when in 
conjunction with other imaging modalities. Ly et al. found that fundus photography 
has 61% accuracy in diagnosing ARMD and its accuracy was proven by 5% with 
additional imaging [18]. This was also documented in Figure 1 that the FP image 
only shows the presence of drusen but upon OCT examination, subretinal and 
fibrovascular pigment epithelial detachment is evident. FP alone is inadequate to 
Figure 1. 
Drusen appearance on FP and OCT of the same patient. The color fundus photography (FP) shows the presence 
of soft drusen and hard drusen at the inferior to fovea (A). Upon OCT examination, the presence of drusen 
is noticeable as a low mounds on the RPE layer. The OCT also shows that subretinal fluid and fibrovascular 
pigment epithelial detachment are also evident on the OCT (B) and (C) indicating a typical wet ARMD.
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diagnose wet ARMD as it underestimates the presence of choroidal neovasculariza-
tion. Hence, another modality is needed to complement FP limitations.
3.2 The fundus autofluorescence
Fundus autofluorescence (FAF) is an imaging method using a specific wave-
length of light to trigger the fundus fluorescent characteristics without the need of 
contrast [7, 13, 15]. This autofluorescence characteristic is mainly due to lipofuscin, 
by-product of RPE, with its toxic component biretinoid fluorophore [7, 19, 20]. 
Specific wavelength of light around 300–500 nm is used to excite the lipofuscin, 
which then emits 500–700 nm [15]. FAF is done using fundus spectrophotometer, 
confocal scanning laser ophthalmoscope, or a fundus camera. Confocal scanning 
laser ophthalmoscope (cSLO) is more superior to others as it has capability to 
reduce the noise from other autofluorescence sources commonly from anterior 
segment of the eye [15, 19]. In comparison with color fundus photography, fundus 
autofluorescence has the ability to detect retinal changes in early and intermediate 
ARMD that may appear normal in color fundus photography [19].
FAF images have the capability to detect numerous retinal abnormalities such 
as pigmentary changes, drusen, and reticular pseudodrusen [19]. Lipofuscin 
deposits in RPE exhibit hyperautofluorescence due to the presence of N-retinyl-N-
retinylidene ethanolamine (A2E), while RPE atrophy appears hypoautofluorescence. 
The condition where these hyperautofluorescence and hypoautofluorescence 
coincide suggests that an area of hyperautofluorescence (lipofuscin) surrounding 
a hypoautofluorescence could be a predictive tool for enlargement of RPE atrophy 
and thus useful for monitoring GA progression. This was exhibited by Gobel et al. 
who discovered enlargement of GA mainly occurred in area of hyperautofluores-
cence and the size increases four times the original size within 9 years of follow-up 
[15]. This corresponds to the hypothesis of lipofuscin containing toxic that causes 
the RPE cell death [20, 21].
Meanwhile, drusen appears in numerous fashions on imaging. In FAF, drusen 
can appear as hypoautofluorescence, hyperautofluorescence, and normal lesion, 
owing to the variability of fluorophore components and the size of drusen [19]. 
Hard drusen, especially small ones, is hard to detect using FAF. Soft drusen under 
FAF appears as hyperautofluorescence around the edges and slightly hypoauto-
fluorescence in the center. Reticular pseudodrusen resembles as a well-organized 
network hypoautofluorescence lesion surrounding the normal retina. This is 
hypothesized due to its subretinal location that obstructs the autofluorescence of 
lipofuscin in RPE [19, 22].
A patchy pattern, reticular pattern, and linear pattern documented on FAF 
have been associated with the development of neovascular ARMD. Cohort study 
by Batioglu et al. discovered that initial findings of patchy pattern were the most 
associated FAF pattern linked with the development of exudative ARMD with 
frequency rate of 30.4%, followed by linear pattern and reticular pattern (25 and 
20.8%, respectively) during 2.5 years' follow-up, showing that FAF is useful as a 
prognostic tool to predict the incidence of neovascular ARMD [23]. Similar find-
ing was also exhibited by Cachulo et al., whereas the patchy pattern was the most 
associated FAF pattern abnormality converted to exudative ARMD (29%) [24].
In neovascular ARMD, FAF images exhibit various FAF pattern. Hemorrhages, 
scarring, and fibrovascular membranes are hypoautofluorescence lesion. Subretinal 
fluid appears as hyperautofluorescence. Break in RPE exhibits as reduced autofluo-
rescence [19]. In classic neovascular ARMD, Peng et al. described the FAF findings 
as reduced FAF at the lesion core with elevated FAF around the lesion border. The 
author also compared the FAF image with fundus fluorescence angiography; the 
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lesion on FFA appeared smaller than that in FAF showing that FAF has more advan-
tages in detailing the alteration in RPE. In occult neovascular ARMD, FAF images 
exhibit diverse FAF characteristics with both reduced FAF and elevated patchy FAF 
[25]. FAF has high sensitivity in detecting neovascular ARMD (93%) but relatively 
low specificity (37%) in comparison with FFA as the gold standard [24].
Near-infrared autofluorescence (NIA) is another imaging technique that 
utilizes the other fluorophore characteristics of retina, melanin. Melanin is found 
predominantly in RPE cell and small amount in choroid. Unlike the ordinary FAF, 
NIA adapts longer wavelength (diode laser light) for excitation 787 nm and capture 
specific wavelength above 800 nm. The image is captured using confocal scanning 
laser ophthalmoscope, producing 30 × 30° images [26, 27]. In visualizing the retina, 
NIA exhibits comparable retina characteristics taken by FAF. The NIA images 
show high hyperautofluorescence in the center of fovea owing to the high melanin 
contents in RPE cells [26]. In dry AMRD patients, both NIA and FAF appear dark 
in atrophic region, meanwhile the area adjacent to the atrophic region appeared 
increased intensity. Kellner et al. found that half of their ARMD patients have 
increased NIA in normal FAF site; the author suggests that there is an increase in 
melanin activity prior to lipofuscin activity [27]. In wet ARMD, the image appears 
dark in both NIA and FAF due to obstructed autofluorescence signal by subretinal 
fluid, hemorrhage, or choroidal neovascularization. However, it was found that FAF 
(56.5%) is more effective in detailing exudative activity compared to NIA (33.9%) 
[27]. Figure 2 shows the comparison of regular fundus autofluorescence and 
infrared autofluorescence.
Retromode imaging (RM) is another imaging modality employing infrared laser 
at 790 nm, equipped with a laterally deviated confocal aperture with central stop. 
The imaging utilizes confocal scanning laser ophthalmoscope, yielding a pseudo-3D 
appearance of deeper retinal layers and choroid. This imaging modality is found to 
be useful in identifying pathological structures in dry and wet ARMD. It was found 
that drusen was more apparent in retromode imaging compared to fundus photog-
raphy, and even smaller-size drusen is easily detected [28]. In wet ARMD, Pilotto 
et al. found that RM has a superior intermethod agreement with OCT in visualizing 
macular edema, but relatively low for RPE detachment and poor for neuroretinal 
detachment [29].
Figure 2. 
Fundus autofluorescence of wet ARMD. BluePeak Autofluorescence (BAF) shows a hypoautofluorescence at 
the fovea and perifovea due to macular detachment accompanied by exudates. Meanwhile in infrared (IR) 
autofluorescence, the macular detachment and exudates appear as hyperautofluorescence; the reduced IR was 
blocked due to probable subretinal fluid and hemorrhage.
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3.3 Fundus fluorescence angiography
Fundus fluorescence angiography (FFA) is an invasive imaging modality that 
uses intravenous fluorescent contrast called resorcinolphthalein sodium. FFA serves 
as the gold standard for neovascular ARMD. It allows visualization of the blood ves-
sel structure and integrity. A camera with a ring-shaped flash 485–500 nm is used 
to excite the molecule in the contrast. The projected blue light is then reflected back 
by retina layers. Some light is absorbed by the fluorescein and emits back as green 
light at wavelength of 520–535 nm. The emitted green light is then captured by 
520–535 nm green filter onto digital surface, producing image at 2.5× magnification 
and 30° of angle view. In FFA, there is early state and late state [14].
Compared to other modalities, FFA excels in detailing the state of choroid 
neovascularization in its structural and leakage state. Based on the location of CNV, 
it is classified as extrafoveal, subfoveal, and juxtafoveal. Extrafoveal CNV is neovas-
cular located around 200–2500 μm from the center of foveal avascular zone (FAZ). 
Subfoveal CNV is located underneath the center of FAZ. Lastly, juxtafoveal CNV 
is located up to 199 μm from the center of FAZ and some part of FAZ excluding the 
center portion [14]. Identification of the CNV location is a useful prognostic factor 
and treatment options.
FFA also provides leakage property of the CNV, which is then further clas-
sified into occult CNV (type I), classic CNV (type II), and retinal angiomatous 
proliferation (type III) [6, 14, 22]. Occult CNV appears as poorly defined mottled 
and patchy hyperfluorescence in early-phase angiogram and leaks at the later phase 
of angiogram, forming larger hyperfluorescence dots. The occult CNV is further 
classified based on its leakage characteristics found upon FFA examinations. Type 
I occult CNV is fibrovascular PED and is described as stippled hyperfluorescence 
upon early phase (1–2 minutes after fluorescein dye injection) followed by poorly 
defined progressive leakage upon late-phase angiogram (Figure 3). Type II occult 
CNV is late leakage from undetermined source and is described as CNV does not 
appear hyperfluorescence during early phase but shows speckled hyperfluorescence 
upon mid- to late-phase angiogram (2–5 minutes after dye injection) [30]. Classic 
CNV presents as well-defined hyperfluorescence network membrane in early phase, 
followed by progressive leakage in late-phase angiogram [14, 22].
Another neovascularization lesion often found in ARMD patients is retinal 
angiomatous proliferation (RAP). RAP is recently described as neovascularization 
arising from intraretinal layer and infiltrating into the choroid layer forming a 
retinal-choroidal anastomosis (RCA) [22]. According to classification by Yannuzzi 
et al., there are three stages of RAP. Stage I is intraretinal capillary proliferation ris-
ing from deep capillary plexus in paramacular region [31]. Upon FFA examination, 
Figure 3. 
Fundus fluorescence angiography ((FFA) characteristics of occult CNV, fibrovascular PED type. The early 
phase (A) shows a stippled hyperfluorescence followed by progressive increase of hyperfluorescence at mid-
phase (B) and late-phase angiogram (C).
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it appears as well-defined border of hyperfluorescence at the focal area surrounded 
with intraretinal edema [32]. Stage II is defined as neovascularization that has 
extended through photoreceptor layer infiltrating into subretinal space [31]. FFA 
reveals a hyperfluorescence at focal area indicating intraretinal neovascularization 
and at subretinal spaces followed by subretinal leakage, often interpreted as occult 
CNV [32]. Stage III is described as the presence of choroid neovascularization 
(CNV), anastomosis of retina and choroid, and pigment epithelial detachment [31]. 
On FFA examination, sometimes it is difficult to detect stage III as the detailed layer 
of subretinal neovascularization, choroid neovascularization, and detached RPE 
combined into homogenous nonspecific hyperfluorescence [32]. Hence, another 
imaging technique such as indocyanine green angiography is needed to offer a bet-
ter visualization of the lesion.
Drawbacks of the FFA procedure are its systemic complication from the injected 
fluorescent dye. The complications are nausea, allergic reaction, and anaphylaxis 
reaction. The dye used leaks extensively to the sur rounding tissue, which could alter 
detailing of the CNV. Thus in some cases of type I CNV, PCV, and RAP, ICGA is the 
more preferable method compared to FFA [33].
3.4 Indocyanine green angiography
Indocyanine green angiography (ICGA) uses indocyanine green dye, a high-
molecular weight contrast (775kD), and projects 790 nm infrared light directed into 
the eyes that allows deep penetration to the RPE structure [14, 22]. The dye used in 
ICGA binds to plasma proteins and thus leaks less compared to FFA imaging. The 
ICGA leakage then reabsorbed, thus producing hypercyanescent in the late phase 
[13, 14]. Similar to FFA, ICGA is an invasive procedure using injection of intravenous 
dye into the systemic circulation, which could trigger systemic complication such as 
nausea, vomiting, urticarial, allergic reaction, and anaphylactic reaction [14].
Abnormalities exhibited by ICGA appear as hypercyanescent plaque, focal hot 
spot, or combination of both. ICGA readings have three timed phase, early phase, 
mid phase, and late phase. ICGA is well suited in identification of type I CNV or 
occult CNV, the early phase often showing ill-defined hypercyanescent lesion, pro-
gressive intensity in mid phase, and the late-phase hypercyanescent plaque [33, 34]. 
However, ICGA is less superior in detecting classic CNV; this type of CNV appears 
as well-defined hypercyanescent [34].
Other types of CNV pivotal in determining the treatment options and outcome 
are polypoidal choroidal vasculopathy (PCV) and retinal angiomatous prolifera-
tion (RAP). Polypoidal choroidal vasculopathy (PCV) is described as branching 
of abnormal choroidal vascular network with aneurysmal dilatation (polypoidal 
characteristics) at its edge. The exact origin of PCV is still in dispute; some suggest 
that PCV arises from choroidal abnormalities, while others speculate that PCV is 
another type 1 CNV modification [35–37]. Upon FFA imaging, PCV often masks 
the appearance of occult CNV or classic CNV and thus ICGA serves as the gold 
standard in identification of PCV as its appearance masked by the RPE layers in 
FFA. On ICG angiography examination, PCV appears as hypercyanescent hot spot 
in the early angiogram with a grape-like/polypoid structure (Figures 4 and 5) [38]. 
Figure 5 is an example where PCV lesion masking an occult CNV on FFA and the 
ICGA examination revealed hypercyanescent hot spot with polypoid structure upon 
early, mid, and with “wash out” phenomenon in late-phase angiogram.
The occurrence of PCV has been associated with serosanguineous PED, neu-
rosensory detachment, high recurrent case, and poor visual outcome [38]. It was 
found that the poor outcome despite the effective treatment of anti-VEGF should 
always suspect the occurrence of PCV [39].
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Retinal angiomatous proliferation (RAP) is also a type of CNV best visualized by 
ICGA. This lesion appears as early hyperfluorescence hot spot with apparent retinal 
artery communication into the CNV, followed by progressive increase in both size 
and intensity in the late phase [32, 40]. Identification of RAP on one eye has been 
linked with the increased chance of neovascularization on the other eye reaching 
almost 100% risk within 3 years of follow-up [41].
Figure 5. 
FFA image shows appearance of what looks like occult CNV. Ill-defined stippled hyperfluorescence is visible 
upon early phase (A), progressively increasing in intensity during mid-phase (B) and late-phase angiogram 
(C). However, upon ICGA examination, the lesion appears to have PCV characteristics. “Hot-spot” with 
polypoid appearance is evident upon early angiography (D) followed by progressive intensity upon mid 
phase (E) and “wash-out” on late phase (F). The choroidal structure is blocked by the presence of massive 
submacular hemorrhage, which appears as hypofluorescence background.
Figure 4. 
ICGA examination of a patient (A) early phase at 1 minute 45 seconds shows a well-demarcated 
hypercyanescent lesion with polypoidal characteristics (B) increasing intensity at mid phase at 3 minute 
51 seconds and late phase 5 minute 59 seconds (C) indicating PCV lesion.
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As mentioned before, ICGA operates on longer wavelength of infrared com-
pared to FFA, thus allowing deeper penetration to RPE and choroidal structure 
providing more specific information regarding CNV location [14, 22]. These advan-
tages also allow the image to further penetrate any subretinal fluid or hemorrhages 
and pigment epithelium detachment that often alter imaging in FFA. Kramer et al. 
found that upon FFA examination, most of their patients with retinal hemorrhage 
exhibit ill-defined hyperfluorescence surrounded with area of blocked fluorescence 
(23/30), while under ICGA, these lesions appear to be hypercyanescent hot spot in 
12 cases, plaque in 8 cases, and combination in 8 cases [40]. Thus in the presence 
of hemorrhage, ICGA image offers more detailed characteristics of CNV in ARMD 
patients compared to FFA.
3.5 The utilization of optical coherence tomography in age-related macular 
degeneration
Optical coherence tomography (OCT) is performed by projecting low coher-
ence laser into retina. The image is a product of time delay and backscattered lights 
resulting in cross section of retina layers [13, 14]. Time domain OCT (TD-OCT) 
is the first OCT invented and requires longer time to produce image. TD-OCT 
produces axial and later resolution 15 μm. Spectral domain OCT requires less time 
to acquire images, resulting in greater density and better image quality (axial 3 μm, 
transverse resolution 10 μm) [14, 22]. Polarization-sensitive SD-OCT (PS-SD-
OCT) is a modified form of SD-OCT in purpose to overcome limitation to detect 
RPE unity and condition [42]. Lastly, the newly developed swept-source OCT uses 
longer wavelength and simpler methods and thus enables deeper tissue penetration 
and shorter duration of image acquisition compared to SD-OCT.
Image produced by OCT is in the form of hyperreflective and hyporeflective 
bands representing the layer of retina [43]. In clinical practices, there are four 
hyperreflective bands that are observed in ARMD patients. These hyperreflective 
bands are presumed to represent external limiting membrane, inner/outer seg-
ment of photoreceptor, RPE, and Bruch’s membrane [44]. OCT is capable to exhibit 
ARMD abnormalities such as drusen deposits, pseudodrusen, subretinal fluid, RPE 
detachment, and choroid neovascularization. In OCT, drusen deposits appear as 
low mounds underneath RPE layer [22]. Findings of drusen in OCT are found to be 
significantly correlated with drusen findings in FAF in the study of Landa et al. [45].
Reticular pseudodrusen presents as hyperreflective deposit localized under the 
retina layer [22]. The presence of pseudodrusen in ARMD patients has been linked 
with the increased risk for end-stage ARMD, geographic atrophy, or neovascular 
ARMD. Ueda-Arakawa et al. found that OCT has the highest sensitivity (94.6%) 
and specificity (98.4%) in detecting the presence of pseudodrusen in comparison 
with other imaging modalities [46]. The presence of reticular pseudodrusen also 
alters the choroid function proven by thinning of choroid thickness [47, 48].
In geography atrophy, the RPE atrophy exhibits a feathered-like pattern projected 
deep into the RPE due to laser beam penetrated into RPE [14]. OCT images also exhibit 
a progressive loss of retinal bands, which includes external limiting membrane, inner/
outer segments of photoreceptor layer, RPE membrane, and outer nuclear membrane 
[15]. These findings are in concordance with the study of Fleckenstein et al.; the 
authors discover that the enlargement of the atrophic region was associated with 
gradual loss of the outer hyperreflective bands and thinning of outer nuclear layer, 
outer plexiform layer, RPE membrane, and Bruch’s membrane during 12 months of 
follow-up [49, 50]. The authors also discovered that GA was linked with increased of 
retinal thickness by 14.09 μm [49]. Their other study also found separation of inner 
and outer parts of band 4, presumed to be RPE/Bruch’s membrane [50].
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Neovascularization activity is visualized on OCT based on accumulation of fluid 
in various levels of retina. Subretinal fluid is described as hyporeflective lesion 
located above the RPE and beneath the retina [14, 22]. RPE detachment appears as 
dome shaped at RPE layer [14]. The exudative activity is one of determining factors 
for neovascular ARMD treatment. Increased choroid thickness could represent the 
possible choroid; however, these cannot differ between classic ARMD and polypoi-
dal choroidal vasculopathy [22]. Another structural abnormality of the retina found 
in OCT is outer retinal tubule. This lesion appears as hyporeflective center sur-
rounded by hyperreflective border. Outer retinal tubule represents the degenerated 
photoreceptors and thus does not represent exudative activity for neovasculariza-
tion and does not need treatment for neovascular ARMD [51].
OCT is one of the most convenience imaging modalities to detect and monitor 
ARMD. It provides information of retinal changes without an invasive procedure and 
systemic complication as required in invasive angiographic imaging such as fundus 
fluorescence angiography (FFA) and indocyanine green angiography (ICGA). OCT 
is reported to have higher sensitivity in detecting CNV (94%) compared to FP (78%) 
[17]. However, comparing OCT to FA as the gold standard for CNV, OCT possesses 
lower sensitivity (40%) and relatively moderate specificity (69%) [52]. Unfortunately, 
the advancement of OCT still has limitation in detailing and grading CNV. Figure 
6 exhibits the utilization of multimodal imaging in wet ARMD resulting in detailed 
characteristics of RAP after OCTA successfully provided the appearance of CNV in all 
retina and choroid layer. This shows that the limitation can be overcome by conducting 
fundus fluorescence angiography or OCTA in conjunction with OCT when indicated.
3.6 The new advance in retinal imaging for age-related macular degeneration
OCT technology is continuously developed. The previously developed spectral domain 
OCT (SD-OCT) has limitation in detecting structures under hemorrhage and capturing 
Figure 6. 
Multimodal imaging on a neovascular ARMD patient. The color fundus photography exhibits pale macula 
with the presence of drusen, hard exudate on color fundus photography, and macular detachment (A). Upon 
OCT examination, pigment epithelial detachment is apparent along with subretinal fluid (B). Meanwhile, on 
OCTA examination, choroidal neovascularization is evident arising from choroid layer (H), choriocapillaris 
layer (G), avascular zone (F), extending into deep vascular layer (E) and superficial vascular layer (D), 
which is a characteristic of typical RAP.
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the integrity of RPE layers. It was then proposed by Ahlers et al. [42], where the SD-OCT 
was modified adding its capability to detect depolarization characteristics of RPE layers, 
called polarization-sensitive (PS) SD-OCT. The use of PS-SD-OCT was observed in both 
dry and wet ARMD. The PS-SD-OCT was successful in visualizing the continuous layer of 
RPE located under the drusen, larger RPE atrophy area, and focal skip lesions in the RPE 
layer, which was unable to be visualized using the standard SD-OCT [42].
Another modification of OCT is done by implementation of adaptive optics (AO). 
OCT has a greater capability in producing high axial resolutions; however, its trans-
verse resolution is limited due to the ocular aberration. This aberration is due to cornea, 
crystalline lens, and the size of the pupil. AO aids in correction of ocular aberrations, 
increases lateral resolutions, reduces artifacts, and increases detection to weak reflec-
tions [53]. Combining these two techniques enhances OCT capability, thus allowing 
visualization of cellular structures; hence, early recognition of cellular pathology 
afore the visual alteration occurs. A comparison of commercial B-scans OCT with 
AO-OCT resulted higher reflectivity and reduced speckle size in retina images taken 
with AO-OCT [54]. Utilization of AO-OCT in ARMD has been documented in several 
studies. One of the studies conducted by Athanasios et al. shows the application of 
AO-OCT in geographic atrophy patients. The AO-OCT successfully provided detailed 
extralimiting membrane loss, inner and outer segment loss, and RPE loss in geographic 
atrophy (GA). In advanced GA, the AO-OCT capable of visualizing calcified drusen 
and drusenoid pigment epithelial detachment. This modification also allows the clini-
cians to directly witness the destruction of photoreceptor cell caused by drusen [55].
In 2008, swept-source OCT (SS-OCT) was introduced. This new technique 
uses tunable laser, which possesses longer wavelength (1050 nm) for deeper tissue 
penetration and predivided spectrum for simpler mechanisms, hence faster image 
acquisition [56]. Therefore, SS-OCT is greater in visualizing the choroidal structure 
and RPE. In comparison to SD-OCT, SS-OCT has greater capability in identifying 
retinal thickness. It was found that the agreement between these two methods of 
OCT is low, especially in those with active wet ARMD [57]. The author argues that 
the active disease, such as hemorrhage and subretinal fluid, obscures the OCT 
signals in SD-OCT. The superiority of SS-OCT is also supported by Copete et al. 
[58]; the SD-OCT was unable to identify choroidosclera border in those with thicker 
choroid (23%) upon SS-OCT examination. The odd ratio of SD-OCT failure is 
greatest (10.3) at 400 μm of subfoveal choroidal thickness.
Age-related macular degeneration affects elderly; thus the use of fluorescence dye 
results in worse side effects. However, the visualization of retina and choroidal micro-
vasculature in ARMD detection is crucial in management of ARMD. Thus, the devel-
opment of noninvasive angiographic imaging technique is essential. The advancement 
of OCT technology helps in the development of OCTA. The shortened OCT image 
acquisition allows the development of OCTA as multiple image retrieval is required. 
The breakthrough in OCTA began after the discovery in OCT signal differences caused 
by blood flow. This contrast is classified as Doppler phase shift and speckle variance 
[59]. However, Doppler phase shift is found to be ineffective to visualize retinal and 
choroidal microvasculature [59]. It was then discovered in 2005 by Barton et al. where 
the speckle variation in OCT signal arises from scatterer motion. Speckle variation was 
further classified into phase based and amplitude or intensity.
OCTA is a noninvasive imaging examination that allows visualization of retina and 
choroid vascular structure. By utilizing the principle of OCT, it detects erythrocyte 
flow using sequential B-scans to detect the variable amplitudes and signal intensity 
gradients. This gradient is then processed through full-spectrum or split-spectrum 
processing [22, 59, 60]. It can produce en face or cross-sectional image displaying neo-
vascular network. En face OCTA is the most commonly utilized technique in clinical 
practices. This allows visualization of vascular characteristics from retina, superficial 
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vascular, deep vascular, avascular zone, choriocapillaris zone, and choroid zone. 
However, OCTA does not allow any leakage property of the vascular zone [22, 47].
OCTA is best to describe abnormalities existing in both exudative and nonexuda-
tive CNV. In nonexudative CNV, the use of OCTA is beneficial in visualizing chorio-
capillaris blood flow, especially in atrophy region. Kvanta et al. found a significant 
decrease in choriocapillaris flow in atrophic zone extending outside the geographic 
atrophy area. This could potentially describe the choriocapillaris alteration in dry 
ARMD [61]. OCTA was also used in the study of Toto et al. in which the author found 
significant decreased vessel density by 9% in dry ARMD patients in both superficial 
vascular layer and deep vascular layer compared with healthy individuals [48]. 
However, reading OCTA in dry ARMD should be done in careful manner because the 
drusen affects the signal, thus lowering image quality especially for area below drusen.
OCTA allows to visualize the neovascular network afore the leakage, hence early 
detection and prompt treatment. CNV appears as hyperfluorescence high flow 
network varying on the depth of the retina involvement according to the degree 
of CNV [22]. OCTA has been proven to have a comparable detection capability in 
visualizing CNV compared to other imaging such as FFA and ICGA. Type I CNV 
appears on the choriocapillaris layer penetrating the Brusch’s membrane and below 
the RPE [62]. This CNV appears as a minimal demarcated vascularization arising 
from choroid, choriocapillaris, and RPE with no evidence of neovascularization 
in outer retina [63]. A retrospective case series by Roisman et al. found that OCTA 
exhibits more detailed images in detecting CNV compared to FFA and ICGA in 
asymptomatic ARMD patients [64]. In their study, the authors discover that CNV, 
which appears on FFA as a minimal leakage and macular plaques on ICGA, was a 
type I CNV in OCTA imaging. However, this finding is contradict with the study 
conducted by Told et al. in which the capability of OCTA to detect occult CNV was 
found to be less sensitive and specific compared to ICGA [65].
Meanwhile, type II CNV presents as choroidal neovascularization arising into 
RPE and subretinal space [22]. It appears as a sharp demarcated vascular changes 
Figure 7. 
Color fundus photography shows an appearance of drusen surrounding the macula. The presence of exudates 
due to subretinal fluid is also evident, showing characteristics of wet ARMD (A). The OCT image shows the 
presence of macular edema with intraretinal and subretinal fluid; hyperreflective lesion is also noted below 
the RPE suggesting choroid neovascularization (B). The presence of choroid neovascularization is confirmed 
by OCTA, arising from choroid (H), choriocapillaris (G), avascular zone (F), into deep vascular layer (E), 
except superficial vascular layer (D), exhibiting a type III CNV.
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at the choroid, choriocapillaris, RPE, and extending to outer retina [63]. Lastly, the 
appearance of RAP or type III CNV is hyperreflective cluster situated in outer retinal 
layer with interconnecting vessel with the inner retinal circulation (Figure 7) [66]. 
Comparing OCTA and FFA in detecting exudative ARMD, OCTA has lower sensitiv-
ity 81.3% where large subretinal hemorrhage was found on the false-negative patient. 
The authors argue that the subretinal hemorrhage weakens the OCTA signal to detect 
CNV [67]. Another limitation of OCTA was documented in Told et al. and Costanzo 
et al., which OCTA tends to underestimate the CNV size compared to ICGA [33, 65].
The ongoing development of OCT affects greatly in the development of OCTA. The 
most common OCT system used by OCTA is SD-OCT. However, some suggest that the 
SS-OCT system provides more superior image quality compared to SD-OCT system 
in the presence of intraretinal hemorrhage. The longer wavelength used in SS-OCT 
system is thought to be able to penetrate any obscuring materials such as hemorrhage 
or subretinal fluid and thus provides more detailed structure on RPE and choroidal 
layer for ARMD patients. Miller et al. found that the CNV areas appeared to be larger 
upon SS-OCTA compared with SD-OCTA both on 3 × 3 and 6 × 6 mm2 scans [68].
4. Conclusions
Early diagnosis of age-related macular degeneration has the major role in 
delaying the progression of advanced ARMD. The advance in technology provides 
detailed structure of retina alteration in ARMD without the need of invasive proce-
dure. The utilization of multimodal imaging in diagnosis of ARMD results in early 
detection and comprehensive management of ARMD.
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